Follow
Dr Zafar Iqbal MPhil PhD PDr
Dr Zafar Iqbal MPhil PhD PDr
CAMS-Al Ahsa, King Saud Bin Abdulaziz University for Health Sciences, KAMC, NGHA, KSA
Verified email at ksau-hs.edu.sa - Homepage
Title
Cited by
Cited by
Year
MicroRNA-4739 regulates osteogenic and adipocytic differentiation of immortalized human bone marrow stromal cells via targeting LRP3
M Elsafadi, M Manikandan, NM Alajez, R Hamam, RA Dawud, ...
Stem Cell Research 20, 94-104, 2017
402017
Immunological evaluation of β-thalassemia major patients receiving oral iron chelator deferasirox
A Aleem, Z Shakoor, K Alsaleh, F Algahtani, Z Iqbal, A Al-Momen
J Coll Physicians Surg Pak 24 (7), 467-471, 2014
142014
Distinct gene mutations, their prognostic relevance and molecularly targeted therapies in acute myeloid leukemia (AML)
M Tayyab, M Khan, Z Iqbal, S Altaf, Z Noor, N Noor, T Akhtar
OMICS International, 2014
52014
A comparison of two techniques of preparing bone marrow aspirate slides
A Aleem, K Alsaleh, M Aljabry, S Aziz, Z Iqbal, A Almomen
J Pak Med Assoc 66 (5), 528-7, 2016
22016
Case study of primary imatinib resistance and correlation of BCR-ABL multiple mutations in chronic myeloid leukemia
Z Iqbal, RT Siddiqui, JA Qureshi, AM Khalid
Therapy 1 (2), 249-254, 2004
22004
Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid Leukemia. Biology. 2021; 10 (11): 1182
Z Iqbal, M Absar, T Akhtar, A Aleem, A Jameel, S Basit, A Ullah, S Afzal, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
12021
First report of coexistence of sickle cell disease and neurofibromatosis Type 1 in a Saudi patient with family history of neurofibromatosis Type 1
N Alanazi, I Almubarak, Z Almoosa, Z Iqbal
Journal of Applied Hematology 10 (1), 33-35, 2019
12019
Pediatric hematology and oncology in Pakistan
MM Taj
Pediatric hematology and oncology 11 (1), 27-31, 1994
11994
Clinical Validation Of ANKRD36 Mutations As A Novel Biomarker For Monitoring Early Progression and Timely Clinical Interventions In Blast Crisis CML
N Al-anazi, M Absar, A Siyal, S Basit, M Shammas, A Mahmood, ...
Preprints, 2024
2024
In-Depth Integrated Genomic Investigations Identify a Missense Mutation in a Novel Transcription Factor Gene Associated with Blast Crisis Chronic Myeloid Leukemia: Hunt for …
N Alanzazi, S AlMukhaylid, Z Iqbal
Available at SSRN 4607068, 2023
2023
Evaluation of Absolute Neutrophil Count, Band Count and Morphological Changes in Neutrophils in Bacterial Infections
S Latif, H Iqbal, J Zafar, T Chughtai, S Parveen, A Mujahid
Pakistan Journal of Medical & Health Sciences 17 (04), 36-36, 2023
2023
A Winning New Combination? Toward Clinical Application in Oncology
Q Maqsood, A Sumrin, M Iqbal, N Hussain, M Mahnoor, M Zafar Saleem, ...
Cancer Control 30, 10732748231175240, 2023
2023
Investigations on Clinical Validation of mutated ANKRD36 as a Novel Molecular Biomarker for Monitoring Early Progression and Timely Therapeutic Interventions in Blast Crisis CML
N Alanzazi, M Absar, MA Shammas, S Basit, A Siyal, A Mahmood, ...
medRxiv, 2023.12. 28.23300606, 2023
2023
CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML
M Absar, N Alanazi, A Siyal, M Shammas, A Mahmood, S Basit, ...
Journal of Population Therapeutics and Clinical Pharmacology 29 (02), 311-320, 2022
2022
Chronic Myeloid Leukemia-Therapy: Poster II
Z Iqbal, M Iqbal, T Akhtar, MI Naqvi, AH Tahir
2010
Institute where work was done
Z Iqbal, JAQRT Siddiqui
Molecular Genetics of Core Binding Factor Acute Myeloid Leukemia
IMI OrBito, Z Iqbal, T Akhtar
The system can't perform the operation now. Try again later.
Articles 1–17